Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened. One postulated link is bacterial fermentation of “indigestible” prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite. We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro. Quantitative PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1–secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture. Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance. These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2. SCFAs raise intracellular calcium in identified colonic L cells. A: Mixed colonic cultures were loaded with fura2-AM. Pseudocolor images of fura2 340:380 nm fluorescence ratio (reflecting [Ca2+]i) shown prior to (basal) and during the application of propionate (1 mmol/L), and after washing with saline. B: Identification of an L cell in the field of view shown in A identified by the fluorescence of Venus (475 nm excitation). C: A representative response of an L and a non–L cell recorded as in A. D: Mean calcium changes in L cells (filled bars) and non–L cells (open bars) after the addition of acetate (1 mmol/L), propionate (1 mmol/L), or CFMB (30 μmol/L) as indicated. Ratios (340:380) in the presence of the test agent were normalized to the mean of the background ratios of each cell measured before addition and after washout of the test compound. Data represent the means ± SEM of the number of cells indicated above each bar. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with baseline and ##P < 0.01 and ###P < 0.001 compared with non–L cells by Student t test. (A high-quality digital representation of this figure is available in the online issue.)](https://figures.cochat.ai/paper-figures/c242c8ac43cc4c669f03082b05300a60/short-chain-fatty-acids-stimulate-glucagon-like-peptide-1-secretion-via-the-g-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFA-induced activation of receptors on enteroendocrine cells can promote gut-brain signaling by inducing hormones such as glucagon-like peptide 1 (GLP1) and peptide YY (PYY), as well as neurotransmitters like GABA and serotonin (276).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [276]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in rodents show that the administration of prebiotics that influences a shift in the gut microbiome toward increased production of butyrate has beneficial effects associated with higher levels of GLP-1 (193–195), as well as hypothalamic expression of pro-opiomelanocortin (196), thereby influencing the hunger-satiety cycle.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [193]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs can stimulate the secretion of GLP-1 and PYY through the FFAR2 and, to a lesser extent, the FFAR3 receptor (Lin et al., 2012;Psichas et al., 2015;Tolhurst et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Tolhurst et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, SCFA can stimulate the release of GLP-1 in vitro and in vivo dependently of the FFA receptor 2 (Figure 1) [237].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [237]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 8×
“Secreted and cellular GLP-1 was extracted as previously described (24), and active GLP-1 was quantified by ELISA (Millipore).”
MethodInfluentialSelf-citationXiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2637002100 · Cited by 731
Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654
Acetate and Propionate Short Chain Fatty Acids Stimulate Adipogenesis via GPCR43
Hong, Y.-H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K.-C., Feng, D. D., Chen, C., Lee, H.-G., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0545 · Cited by 612
Cited by
Items 901–1,000 of 1,015
Liu, T., Zhao, M., Zhang, Y., Xu, R., Fu, Z., Jin, T., Song, J., Huang, Y., Wang, M., & Zhao, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130062 · Cited by 43
The vast landscape of carbohydrate fermentation in prokaryotes
Hackmann, T. J. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae016 · Cited by 53
Rochoń, J., Kalinowski, P., Szymanek-Majchrzak, K., & Grąt, M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i23.2964 · Cited by 44
The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications
Menozzi, E., Schapira, A. H. V., & Borghammer, P. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70029 · Cited by 46
Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk
Koopen, A. M., Groen, A. K., & Nieuwdorp, M. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000357 · Cited by 40
Effects of obesity, energy restriction and neutering on the faecal microbiota of cats
Fischer, M. M., Kessler, A. D. M., Kieffer, D. A., Knotts, T. A., Kim, K., Wei, A., Ramsey, J. J., & Fascetti, A. J. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517002379 · Cited by 44
Diet, gut microbiota composition and feeding behavior
Kim, J. S., & de La Serre, C. B. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.03.026 · Cited by 41
Hansen, A. H., Sergeev, E., Bolognini, D., Sprenger, R. R., Ekberg, J. H., Ejsing, C. S., McKenzie, C. J., Ulven, E. R., Milligan, G., & Ulven, T. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00855 · Cited by 41
Tian, L., Scholte, J., Scheurink, A. J. W., van den Berg, M. A., Bruggeman, G., Bruininx, E. M. A. M., de Vos, P., Schols, H. A., & Gruppen, H. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.08.032 · Cited by 41
Our Little Friends with Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders
Ejtahed, H., Angoorani, P., Soroush, A., Siadat, S. D., Shirzad, N., Hasani‐Ranjbar, S., & Larijani, B. A. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190930110605 · Cited by 43
Caengprasath, N., González‐Abuín, N., Shchepinova, M. M., Ma, Y., Inoue, A., Tate, E. W., Frost, G. S., & Hanyaloglu, A. C. (2020) · iScience · doi:10.1016/j.isci.2020.101449 · Cited by 44
Dong, T. S., Gupta, A., Jacobs, J. P., Lagishetty, V., Gallagher, E., Bhatt, R. R., Vora, P. P., Osadchiy, V., Stains, J., Balioukova, A., et al. (2020) · Nutrients · doi:10.3390/nu12102924 · Cited by 43
Microbiota’s Role in Diet-Driven Alterations in Food Intake: Satiety, Energy Balance, and Reward
Rautmann, A. W., & Serre, C. B. D. L. (2021) · Nutrients · doi:10.3390/nu13093067 · Cited by 47
Ticinesi, A., Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Rio, D. D., Ventura, M., Sgoifo, A., & Angelino, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215493 · Cited by 44
Improvement in adiposity with oligofructose is modified by antibiotics in obese rats
Bomhof, M. R., Paul, H. A., Geuking, M. B., Eller, L. K., & Reimer, R. A. (2016) · The FASEB Journal · doi:10.1096/fj.201600151r · Cited by 44
Schioldan, A. G., Gregersen, S., Hald, S. M., Bjørnshave, A., Bohl, M., Hartmann, B., Holst, J. J., Stødkilde‐Jørgensen, H., & Hermansen, K. (2017) · European Journal of Nutrition · doi:10.1007/s00394-016-1369-8 · Cited by 44
The Crosstalk between Gut Microbiota and White Adipose Tissue Mitochondria in Obesity
Colangeli, L., Marcillo, D. I. E., Simonelli, V., Iorio, E., Rinaldi, T. G., Sbraccia, P., Fortini, P., & Guglielmi, V. (2023) · Nutrients · doi:10.3390/nu15071723 · Cited by 40
El‐Nashar, H. A. S., Taleb, M., El‐Shazly, M., Zhao, C., & Farag, M. A. (2023) · Phytotherapy Research · doi:10.1002/ptr.8067 · Cited by 40
Zhang, K., Zhang, Q., Qiu, H., Ma, Y., Hou, N., Zhang, J., Kan, C., Han, F., Sun, X., & Shi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37609 · Cited by 48
Metaflammation’s Role in Systemic Dysfunction in Obesity: A Comprehensive Review
Crasan, I.-M., Tanase, M., Delia, C., Pîrcălăbioru, G. G., Cîmpean, A., & Ionica, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110445 · Cited by 46
Plasticity of gastrointestinal vagal afferent satiety signals
Page, A. J., & Kentish, S. J. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12973 · Cited by 40
Kuhre, R. E., Christiansen, C. B., Saltiel, M. Y., Wewer Albrechtsen, N. J., & Holst, J. J. (2017) · Physiological Reports · doi:10.14814/phy2.13507 · Cited by 40
Fujiwara, Y., Eguchi, S., Murayama, H., Takahashi, Y., Toda, M., Imai, K., & Tsuda, K. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.68 · Cited by 49
Hira, T., Ikee, A., Kishimoto, Y., Kanahori, S., & Hara, H. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114514004322 · Cited by 39
Gut dysbiosis and metabolic diseases
Bandopadhyay, P., & Ganguly, D. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.031 · Cited by 45
Chaľová, P., Ťažký, A., Škultéty, Ľ., Minichová, L., Chovanec, M., Čierniková, S., Mikuš, P., & Piešťanský, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1110235 · Cited by 43
Gut bacteriome in inflammatory bowel disease: An update on recent advances
Bajaj, A., Markandey, M., Kedia, S., & Ahuja, V. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-024-01541-1 · Cited by 45
Movahednasab, M., Dianat‐Moghadam, H., Khodadad, S., Nedaeinia, R., Safabakhsh, S., Ferns, G. A., & Salehi, R. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01623-w · Cited by 46
Gustducin couples fatty acid receptors to GLP-1 release in colon
Li, Y., Kokrashvili, Z., Mosinger, B., & Margolskee, R. F. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2012 · Cited by 37
G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets
Milligan, G., Ulven, T., Murdoch, H., & Hudson, B. D. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513002249 · Cited by 42
Taguer, M., & Maurice, C. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.366 · Cited by 37
Hartstra, A. V., Nieuwdorp, M., & Herrema, H. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.08.009 · Cited by 41
Obesity-Related Asthma: Immune Regulation and Potential Targeted Therapies
Yuan, Y., Ran, N., Xiong, L., Wang, G., Guan, X., Wang, Z., Guo, Y., Pang, Z., Fang, K., Lu, J., et al. (2018) · Journal of Immunology Research · doi:10.1155/2018/1943497 · Cited by 43
Doroftei, B., Ilie, O., Cojocariu, R.-O., Ciobica, A. S., Maftei, R., Grab, D., Anton, E., McKenna, J., Dhunna, N., & Simionescu, G. (2020) · Molecules · doi:10.3390/molecules25153323 · Cited by 41
Zhao, M., Ren, K., Xiong, X., Cheng, M., Zhang, Z., Huang, Z., Han, X., Yang, X., Alejandro, E. U., & Ruan, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108013 · Cited by 44
Gut microbiota in mental health and depression: role of pre/pro/synbiotics in their modulation
Methiwala, H. N., Vaidya, B., Addanki, V. K., Bishnoi, M., Sharma, S. S., & Kondepudi, K. K. (2021) · Food & Function · doi:10.1039/d0fo02855j · Cited by 40
Shah, N. Z., Abdalla, M. A., Deshmukh, H., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211042145 · Cited by 44
Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System
Jalodia, R., Abu, Y. F., Oppenheimer, M. R., Truitt, B., Meng, J., Chupikova, I., Tao, J., Ghosh, N., Dutta, R. K., Kolli, U., et al. (2022) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10046-z · Cited by 43
Zhang, G., & Hamaker, B. R. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1130685 · Cited by 40
Resistant starch as a novel dietary strategy to maintain kidney health in diabetes mellitus
Koh, G. Y., & Rowling, M. J. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux006 · Cited by 39
Functionality and Therapeutic Values of Fermented Foods
Thapa, N., & Tamang, J. P. (2015) · CRC Press eBooks · doi:10.1201/b18279-3 · Cited by 49
Ma, H., He, K., Zhu, J., Li, X., & Ye, X. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.03.003 · Cited by 37
Type 2 Diabetes and the Microbiome
Barlow, G. M., & Mathur, R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac184 · Cited by 49
Jiménez-González, C., Alonso‐Peña, M., Vélez, P. A., Crespo, J., & Iruzubieta, P. (2025) · Nutrients · doi:10.3390/nu17091580 · Cited by 45
Stanimirov, B., Đanić, M., Pavlović, N., Zaklan, D., Lazarević, S., Mikov, M., & Stankov, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412167 · Cited by 43
Key Questions for Translation of FFA Receptors: From Pharmacology to Medicines
Suckow, A. T., & Briscoe, C. P. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_45 · Cited by 40
Muredda, L., Kępczyńska, M. A., Zaibi, M. S., Alomar, S. Y., & Trayhurn, P. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1364774 · Cited by 40
Bourgot, C. L., Ferret‐Bernard, S., Apper, E., Taminiau, B., Cahu, A., Normand, L. L., Respondek, F., Huërou‐Luron, I. L., & Blat, S. (2018) · The FASEB Journal · doi:10.1096/fj.201800108r · Cited by 39
Tough, I. R., Forbes, S. C., & Cox, H. M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13454 · Cited by 39
Gut carbohydrate inhibits GIP secretion via a microbiota/SCFA/FFAR3 pathway
Lee, E., Zhang, X., Miyamoto, J., Kimura, I., Taknaka, T., Furusawa, K., Jomori, T., Fujimoto, K., Uematsu, S., & Miki, T. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0241 · Cited by 38
Peiris, M., Aktar, R., Raynel, S., Zheng, H., Mumphrey, M. B., Berthoud, H., & Blackshaw, L. A. (2018) · Nutrients · doi:10.3390/nu10101529 · Cited by 40
Wang, A., Dongcheng, C., Zhang, H., Li, Q., Yan, Z., Qiu, Y., Xu, H., & Keji, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.018 · Cited by 40
Lipid mediators and asthma: Scope of therapeutics
Monga, N., Sethi, G. S., Kondepudi, K. K., & Naura, A. S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113925 · Cited by 40
Liu, J., Song, Y., Zhao, Q., Wang, Y., Li, C., Zou, L., & Hu, Y. (2021) · Foods · doi:10.3390/foods10102457 · Cited by 41
Kant, R., Chandra, L., Verma, V. K., Nain, P., Bello, D., Patel, S., Ala, S., Chandra, R., & Antony, M. A. (2022) · World Journal of Methodology · doi:10.5662/wjm.v12.i4.246 · Cited by 39
Roessler, J., Leistner, D. M., Landmesser, U., & Haghikia, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.018 · Cited by 40
Male infertility and the human microbiome
Magill, R. G., & MacDonald, S. M. (2023) · Frontiers in Reproductive Health · doi:10.3389/frph.2023.1166201 · Cited by 56
Park, J., Kim, K., Kim, K., Lee, I., Jeong, H.-S., Kim, Y., & Jang, H.-J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.107 · Cited by 40
Metabolic networks of the human gut microbiota
Selber‐Hnatiw, S., Sultana, T., Tse, W., Abdollahi, N., Abdullah, S., Rahbani, J. A., Alazar, D., Alrumhein, N. J., Aprikian, S., Arshad, R., et al. (2019) · Microbiology · doi:10.1099/mic.0.000853 · Cited by 41
Gong, B., Li, C., Shi, Z., Wang, F., Dai, R., Chen, G., & Su, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1675552 · Cited by 36
Pettinelli, P., Arendt, B. M., Schwenger, K. J. P., Sivaraj, S., Bhat, M., Comelli, E. M., Lou, W. Y. W., & Allard, J. P. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000466 · Cited by 39
Li, N., Cen, Z., Zhao, Z., Li, Z., & Chen, S. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100078 · Cited by 40
The interaction between intestinal microenvironment and stroke
Zhao, L., Xiao, J., Li, S., Guo, Y., Fu, R., Hua, S., Du, Y., & Xu, S. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14275 · Cited by 39
The critical role of gut-brain axis microbiome in mental disorders
Basiji, K., Sendani, A. A., Ghavami, S. B., Farmani, M., Kazemifard, N., Sadeghi, A., Lotfali, E., & Aghdaei, H. A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01248-w · Cited by 58
The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity
Zhuang, Z., Zhou, P., Wang, J., Lu, X., & Chen, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s432344 · Cited by 38
The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases
Neves, A. L., Chilloux, J., Sarafian, M. H., Rahim, M. B. A., Boulangé, C. L., & Dumas, M.-E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.013 · Cited by 36
Effects on satiation, satiety and food intake of wholegrain and refined grain pasta
Cioffi, I., Ibrügger, S., Bache, J., Thomassen, M. T., Contaldo, F., Pasanisi, F., & Kristensen, M. (2016) · Appetite · doi:10.1016/j.appet.2016.08.002 · Cited by 40
FFA2 and FFA3 in Metabolic Regulation
Tang, C., & Offermanns, S. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_50 · Cited by 39
Enteroendocrine Cells: Metabolic Relays between Microbes and Their Host
Plovier, H., & Cani, P. D. (2017) · Endocrine Development · doi:10.1159/000475736 · Cited by 36
Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections
Sérino, M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.010 · Cited by 40
Wang, Y., Wang, A., Alkhalidy, H., Luo, J., Moomaw, E., Neilson, A. P., & Liu, D. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900978 · Cited by 41
Lang, S., Yang, J., Yang, K., Gu, L., Cui, X., Wei, T., Liu, J., Le, Y., Wang, H., Wei, R., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001025 · Cited by 38
Nguyen‐Tu, M., Martínez-Sánchez, A., Leclerc, I., Rutter, G. A., & Xavier, G. D. S. (2020) · Diabetologia · doi:10.1007/s00125-020-05292-4 · Cited by 44
Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
Yeh, C., Chen, Y.-H., Liu, S.-F., Kao, H., Wu, M., Yang, K., & Wu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228729 · Cited by 39
Mio, K., Yamanaka, C., Matsuoka, T., Kobayashi, T., & Aoe, S. (2020) · Nutrients · doi:10.3390/nu12113546 · Cited by 43
Yang, P., & Zhao, J. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2421 · Cited by 39
Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases
Liu, C., Wang, Y., Yang, Y., Zhang, N., Niu, C., Shen, X., & Wu, J. H. (2021) · The FASEB Journal · doi:10.1096/fj.202100939r · Cited by 40
Plasticity of gastro-intestinal vagal afferent endings
Kentish, S. J., & Page, A. J. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.03.012 · Cited by 37
Michels, N. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422419000143 · Cited by 35
Ross, F. C., Mayer, D. E., Gupta, A., Gill, C. I. R., Rio, D. D., Cryan, J. F., Lavelle, A., Ross, R. P., Stanton, C., & Mayer, E. A. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.10.018 · Cited by 40
Wang, J., An, G., Peng, X.-Z., Zhong, F., Zhao, K., Qi, L., & Ma, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133060 · Cited by 41
Obesity and the gut microbiota: implications of neuroendocrine and immune signaling
Romaní‐Pérez, M., Liébana-García, R., Flor‐Duro, A., Bonillo‐Jiménez, D., Bullich‐Vilarrubias, C., Olivares, M., & Sanz, Y. (2024) · FEBS Journal · doi:10.1111/febs.17249 · Cited by 37
The emerging role of microbiota derived SCFAs in neurodegenerative disorders
Wachamo, S., & Gaultier, A. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101012 · Cited by 44
Minireview: The Effects of Species Ortholog and SNP Variation on Receptors for Free Fatty Acids
Hudson, B. D., Murdoch, H., & Milligan, G. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1085 · Cited by 37
Bacterial modulation of visceral sensation: mediators and mechanisms
Lomax, A. E., Pradhananga, S., Sessenwein, J. L., & O’Malley, D. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00052.2019 · Cited by 38
Targeting GPCRs Activated by Fatty Acid-Derived Lipids in Type 2 Diabetes
Gendaszewska‐Darmach, E., Drzazga, A. K., & Koziołkiewicz, M. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.07.003 · Cited by 37
Short-chain fatty acids and regulation of pancreatic endocrine secretion in mice
Ørgaard, A., Jepsen, S. L., & Holst, J. J. (2019) · Islets · doi:10.1080/19382014.2019.1587976 · Cited by 40
Cellular mechanisms governing glucose-dependent insulinotropic polypeptide secretion
Reimann, F. M., Diakogiannaki, E., Hodge, D., & Gribble, F. M. (2019) · Peptides · doi:10.1016/j.peptides.2019.170206 · Cited by 35
Self-citationYao, Z., Cao, Y.-N., Peng, L., Yan, Z., & Zhao, G. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c05691 · Cited by 38
Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment
Chou, Y., Kan, W., & Shiao, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073658 · Cited by 42
Role of microbiome and its metabolite, short chain fatty acid in prostate cancer
Yang, H. J., & Kim, J. H. (2023) · Korean journal of urology · doi:10.4111/icu.20220370 · Cited by 42
Beloqui, A., Alhouayek, M., Carradori, D., Vanvarenberg, K., Muccioli, G. G., Cani, P. D., & Véronique Préat, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00871 · Cited by 35
Distribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract
Adriaenssens, A. E., Reimann, F., & Gribble, F. M. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170047 · Cited by 41
Self-citationSaraiva, A., Carrascosa, C., Ramos, F., Raheem, D., & Raposo, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127022 · Cited by 34
Gościniak, A., Eder, P., Walkowiak, J., & Cielecka‐Piontek, J. (2022) · Nutrients · doi:10.3390/nu14132560 · Cited by 38
The associations of gut microbiota, endocrine system and bone metabolism
Tu, Y., Kuang, X., Zhang, L., & Xu, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1124945 · Cited by 35
Yang, M., Wang, J., Shin, J., Lee, D., Lee, S., Seo, J., Shin, J., Nam, Y., Kim, H., & Sun, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1220044 · Cited by 47
Dietary and Lifestyle Strategies for Obesity
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2024) · Nutrients · doi:10.3390/nu16162714 · Cited by 42
Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes
Song, J., Wang, C., Zhao, T., Zhang, Y., Xing, J., Zhao, X., Zhang, Y., & Zhang, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520436 · Cited by 52
Zhernakova, A., Yassour, M., Hall, L. J., & Collado, M. C. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.05.014 · Cited by 42
Metadata
- Authors
- Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M.
- Affiliations
- Addenbrooke's Hospital (GB)
- Takeda (United Kingdom) (GB)
- Corresponding author
- Reimann, Frank
- Gribble, Fiona M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-01-17
- Volume
- 61
- Issue
- 2
- Pages
- 364-371
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3266401
- OpenAlex
- W2168842536
- Cited by
- 2,404
- References
- 32
- Citations by year
- 2026: 266 · 2025: 233 · 2024: 203 · 2023: 183 · 2022: 245 · 2021: 205 · 2020: 215 · 2019: 151 · 2018: 158 · 2017: 120 · 2016: 132 · 2015: 103 · 2014: 92 · 2013: 65 · 2012: 27
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
- Apollo
- Funders
- Wellcome Trust (084210/Z/07/Z, 088357/Z/09/Z, #WT084210, 088357, 088357/Z/09/A)
- European Commission (2007–2013, 266408)
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, glucagon-like peptide-1, FFAR2, GPR43, GPR41, incretin secretion, gut microbiota, prebiotic fermentation, colonic epithelial cells, calcium signaling, glucose tolerance, diabetes treatment, Gq signaling
- MeSH terms
- Animals, Calcium, Colon, Fatty Acids, Volatile, Mice, Inbred C57BL, Signal Transduction, GTP-Binding Protein alpha Subunits, Gi-Go, Receptors, G-Protein-Coupled, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.